Common Contracts
2 similar null contracts by Cerecor Inc., Elicio Therapeutics, Inc.
COMMON STOCK PURCHASE WARRANT VEDANTRA PHARMACEUTICALS, INC.Elicio Therapeutics, Inc. • July 13th, 2021 • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the ten (10) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Vedantra Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to [ ] shares (the “Warrant Shares”) of the Company’s common stock, par value $0.01 per share (“Common Stock”).
SERIES B NON-VOTING CONVERTIBLE PREFERRED STOCK PURCHASE WARRANT CERECOR INC.Cerecor Inc. • December 27th, 2018 • Pharmaceutical preparations
THIS SERIES B NON-VOTING CONVERTIBLE PREFERRED STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Armistice Capital Master Fund Ltd or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date set forth above (the “Initial Exercise Date”) and on or prior to the close of business on the five year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Cerecor Inc., a Delaware corporation (the “Company”), up to 2,857,143 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Series B Non-Voting Convertible Preferred Stock. The purchase price of one share of Series B Non-Voting Convertible Preferred Stock (“Series B Stock”) under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). The Company previously issued Holder a Common Stock Purchase W
